Listed

Phibro Animal Health Corp

PAHCNasdaqCIK 1069899HealthcareFiscal year ends Jun 30

Latest reported revenue, Q4 FY2026$396.7mRevenue, Q4 FY2026, three months to 2026-06-30$396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2026, from the 10-K filed Aug 26, 2026.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$396.7mRevenue, Q4 FY2026, three months to 2026-06-30$396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure+4.8% on a year earlier
  • Gross margin33.9%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $134.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure+4.8 pts on a year earlier
  • Operating margin12.1%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $48.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure+3.2 pts on a year earlier
  • Net margin5.5%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure+0.9 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow$5.2mFree cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Capital expenditure: $18.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure−35.7% on a year earlier

Last eight quarters

Full statements
Revenue$396.7mGross margin 33.9%
Diluted EPS$0.59, Q3 FY2026
Free cash flow$5.2m, Q4 FY2026
Phibro Animal Health Corp, key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$m260Revenue, Q1 FY2025, three months to 2024-09-30$260.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure309Revenue, Q2 FY2025, three months to 2024-12-31$309.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure348Revenue, Q3 FY2025, three months to 2025-03-31$347.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure379Revenue, Q4 FY2025, three months to 2025-06-30$378.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure364Revenue, Q1 FY2026, three months to 2025-09-30$363.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure374Revenue, Q2 FY2026, three months to 2025-12-31$373.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure384Revenue, Q3 FY2026, three months to 2026-03-31$383.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure397Revenue, Q4 FY2026, three months to 2026-06-30$396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure
Gross margin%32.1%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $83.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $260.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure32.9%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $101.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $309.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure30.1%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $104.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $347.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure29.0%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $110.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $378.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure32.9%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $119.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $363.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure35.5%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $132.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $373.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure32.8%Gross margin, Q3 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $125.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $383.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure33.9%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $134.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure
Operating margin%6.8%Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $260.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure8.3%Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $25.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $309.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure9.6%Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $33.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $347.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure8.9%Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $33.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $378.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure14.1%Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $51.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $363.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure13.5%Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $50.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $373.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure11.6%Operating margin, Q3 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $44.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $383.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure12.1%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $48.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure
Net margin%2.7%Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: $7.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $260.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure1.0%Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: $3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $309.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure6.0%Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: $20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $347.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure4.5%Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: $17.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $378.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure7.3%Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: $26.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Revenue: $363.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure7.3%Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: $27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Revenue: $373.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure6.3%Net margin, Q3 FY2026, three months to 2026-03-31. net income / revenueNet income: $24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Revenue: $383.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figure5.5%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $21.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Revenue: $396.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share0.17Diluted EPS, Q1 FY2025, three months to 2024-09-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure0.08Diluted EPS, Q2 FY2025, three months to 2024-12-31$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure0.51Diluted EPS, Q3 FY2025, three months to 2025-03-31$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figurenot reported (Diluted EPS not reported)0.65Diluted EPS, Q1 FY2026, three months to 2025-09-30$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure0.67Diluted EPS, Q2 FY2026, three months to 2025-12-31$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-04, accession 0001104659-26-010317.Report this figure0.59Diluted EPS, Q3 FY2026, three months to 2026-03-31$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056280.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$m3.0Free cash flow, Q1 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Capital expenditure: $9.6m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure(4.7)Free cash flow, Q2 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-04, accession 0001104659-26-010317. Derived: 6-month figure less the 3-month figure.Capital expenditure: $7.8m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-02-04, accession 0001104659-26-010317. Derived: 6-month figure less the 3-month figure.Report this figure35.4Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $43.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056280. Derived: 9-month figure less the 6-month figure.Capital expenditure: $7.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-06, accession 0001104659-26-056280. Derived: 9-month figure less the 6-month figure.Report this figure8.1Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $21.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Capital expenditure: $13.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Capital expenditure: $13.8m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-05, accession 0001104659-25-107001.Report this figure8.3Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-04, accession 0001104659-26-010317. Derived: 6-month figure less the 3-month figure.Capital expenditure: $11.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-02-04, accession 0001104659-26-010317. Derived: 6-month figure less the 3-month figure.Report this figure0.9Free cash flow, Q3 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056280. Derived: 9-month figure less the 6-month figure.Capital expenditure: $15.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-06, accession 0001104659-26-056280. Derived: 9-month figure less the 6-month figure.Report this figure5.2Free cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Capital expenditure: $18.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493. Derived: 12-month figure less the 9-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.52bnGross margin 33.8%
Diluted EPS$2.43, FY2026
Free cash flow$9.9m, FY2026
Phibro Animal Health Corp, key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m942Revenue, FY2022, twelve months to 2022-06-30$942.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure978Revenue, FY2023, twelve months to 2023-06-30$977.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure1,018Revenue, FY2024, twelve months to 2024-06-30$1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure1,296Revenue, FY2025, twelve months to 2025-06-30$1.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure1,518Revenue, FY2026, twelve months to 2026-06-30$1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure
Gross margin%30.3%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: $285.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-08-28, accession 0001558370-24-012517.Revenue: $942.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure30.5%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $298.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-27, accession 0001558370-25-011776.Revenue: $977.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure30.8%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $313.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure30.9%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $399.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure33.8%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $512.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure
Operating margin%8.4%Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: $79.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-08-28, accession 0001558370-24-012517.Revenue: $942.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure7.3%Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: $71.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-27, accession 0001558370-25-011776.Revenue: $977.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure5.2%Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: $53.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure8.5%Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: $110.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure12.8%Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: $194.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure
Net margin%5.2%Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: $49.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-08-28, accession 0001558370-24-012517.Revenue: $942.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure3.3%Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: $32.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-27, accession 0001558370-25-011776.Revenue: $977.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure0.2%Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: $2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.02bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure3.7%Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: $48.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure6.6%Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: $99.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-08-26, accession 0001104659-26-101493.Revenue: $1.52bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure
Diluted EPS$ per share1.21Diluted EPS, FY2022, twelve months to 2022-06-30$1.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure0.81Diluted EPS, FY2023, twelve months to 2023-06-30$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure0.06Diluted EPS, FY2024, twelve months to 2024-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure1.19Diluted EPS, FY2025, twelve months to 2025-06-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure2.43Diluted EPS, FY2026, twelve months to 2026-06-30$2.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure
Free cash flow$m(5.4)Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: $31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-08-28, accession 0001558370-24-012517.Capital expenditure: $37.0m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2024-08-28, accession 0001558370-24-012517.Report this figure(38.5)Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: $13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-27, accession 0001558370-25-011776.Capital expenditure: $51.8m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-08-27, accession 0001558370-25-011776.Report this figure46.4Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $87.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493.Capital expenditure: $41.2m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure41.8Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $80.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493.Capital expenditure: $38.3m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure9.9Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $69.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-26, accession 0001104659-26-101493.Capital expenditure: $59.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-08-26, accession 0001104659-26-101493.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Phibro Animal Health Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$101.1m3,219,040Reduced−34,808
FMR LLC2026-06-30$99.2m3,160,281Added+987,155
STATE STREET CORP2026-06-30$32.6m1,038,382Added+88,349
MILLENNIUM MANAGEMENT LLC2026-06-30$29.4m936,701Added+880,882
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$29.0m923,318Added+32,035
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$20.6m657,350Added+52,702
DIMENSIONAL FUND ADVISORS LP2026-06-30$16.7m531,087Added+23,235
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$16.0m508,486Added+18,144
RENAISSANCE TECHNOLOGIES LLC2026-06-30$15.1m480,500Reduced−96,235
CastleKnight Management LP2026-06-30$14.5m461,322Added+385,427

Recent filings

All 692 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Phibro Animal Health Corp, recent filings
FiledFormWhat it isAccession number
2026-09-1820:10 ETDEF 14AProxy statementPeriod 2026-11-030001104659-26-108939
2026-08-2620:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-101531
2026-08-2620:14 ET10-KAnnual reportPeriod 2026-06-300001104659-26-101493
2026-07-2820:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-087544
2026-06-2621:07 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-078323
2026-05-2220:24 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-065746
2026-05-0620:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-26-056316
2026-05-0620:25 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-056280
2026-05-0520:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-055699
2026-04-3020:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-26-052956

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Aug 26, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1069899
Tickers
PAHC
Exchange
Nasdaq
SIC code
2834 Pharmaceutical Preparations
Sector
Healthcare
Fiscal year ends
Jun 30
Incorporated in
DE
Filer category
Large accelerated filer
Former names
PHILIPP BROTHERS CHEMICALS INC (to 2003-05-14)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.